Scientists in the United States who study human embryonic stem cells
would find they have much in common with their counterparts in the European
Union (EU), namely, highly polarized opinions on whether such work should
be permitted and an equally divergent range of political support for funding
Federal funding in the United States is currently permitted only for
research using a limited number of embryonic stem cell lines generated before
2001—cells that many scientists say are of poor quality—but generous
funding is surfacing or being considered for stem cell research in some states.
Similarly, the European Commission—the executive body responsible for
EU-wide legislation—offers limited funding for stem cell research, but
the EU’s 25 member nations are left to implement their own regulations.
And because of these countries’ differing cultural and religious traditions,
policies across Europe range from highly permissive to deeply restrictive,
making a consensus unlikely for now.
Bosch X. In Europe, as in US, Climate for Embryo Stem Cell Research Is One of Extremes. JAMA. 2005;293(18):2202-2203. doi:10.1001/jama.293.18.2202